Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protease inhibition is the process of blocking the enzymatic activity of proteases, which are enzymes responsible for cleaving peptide bonds in proteins. This inhibition can be achieved through various mechanisms, including reversible and irreversible binding of inhibitors to the protease active site or through conformational changes. It is a validated drug discovery strategy for treating infectious diseases, cancer, and other pathologies involving aberrant protein degradation pathways.
Inhibition of protease activity through reversible or irreversible binding, preventing protein cleavage.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protease Inhibition.